Evidence map›Paper›PMID 29333980›Full record

ArticleHuman vaccines & immunotherapeutics2018

Percentages of PD-1

Yingying Wang, Nannan Pang, Xinyou Wang, Ying Liu, Xiujuan Wang, Lei Wang, Mingling Sun, Halida Yasen, Fang Zhao, Wenxia Fan and 2 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Expression of PD-1 on CD4Journal of immunology research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yingying Wanga Hematology Disease Center, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China ; Xinjiang Uygur Autonomous Region Research Institute of Hematology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China.
Nannan Panga Hematology Disease Center, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China ; Xinjiang Uygur Autonomous Region Research Institute of Hematology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China.
Xinyou Wanga Hematology Disease Center, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China ; Xinjiang Uygur Autonomous Region Research Institute of Hematology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China.
Ying Liua Hematology Disease Center, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China ; Xinjiang Uygur Autonomous Region Research Institute of Hematology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China.
Xiujuan Wanga Hematology Disease Center, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China ; Xinjiang Uygur Autonomous Region Research Institute of Hematology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China.
Lei Wanga Hematology Disease Center, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China ; Xinjiang Uygur Autonomous Region Research Institute of Hematology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China.
Mingling Suna Hematology Disease Center, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China ; Xinjiang Uygur Autonomous Region Research Institute of Hematology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China.
Halida Yasena Hematology Disease Center, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China ; Xinjiang Uygur Autonomous Region Research Institute of Hematology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China.
Fang Zhaoa Hematology Disease Center, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China ; Xinjiang Uygur Autonomous Region Research Institute of Hematology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China.
Wenxia Fana Hematology Disease Center, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China ; Xinjiang Uygur Autonomous Region Research Institute of Hematology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China.
Xinhong Guoa Hematology Disease Center, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China ; Xinjiang Uygur Autonomous Region Research Institute of Hematology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China.
Jianbing Dingb State Key Laboratory Incubation Base of Major Diseases in Xinjiang, The First Affiliated Hospital of Xinjiang Medical University , Urumqi , P.R. China.
First Affiliated Hospital of Xinjiang Medical University · CNXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study is to measure the expression of programmed death (PD)-1 / programmed death ligand-1 (PD-L1) negative costimulatory molecules, soluble format sPD-1 in patients with immune thrombocytopenia (ITP), and to investigate their correlation with the secretion of cytokines. A total of 35 patients with ITP were included in the present study. Twenty healthy subjects who received physical examination at our hospital were included as control group. Peripheral blood was collected from all ITP patients and healthy subjects. Flow cytometry was performed to determine the percentages of PD-1

Indexed as

AdultB7-H1 AntigenCD4-Positive T-LymphocytesFemaleHumansInterferon-gammaInterleukin-17MalePlatelet CountProgrammed Cell Death 1 ReceptorPurpura, Thrombocytopenic, IdiopathicSignal TransductionB7-H1 AntigenCD274 protein, humanInterferon-gammaInterleukin-17PDCD1 protein, humanProgrammed Cell Death 1 Receptorcytokineprimary immune thrombocytopeniaprogrammed death-1programmed death-ligand 1soluble programmed death-1

Identifiers

PMID29333980
PMCPMC5893189
OpenAlexW2783287606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.